Trademark: 90860790
Word
HEDTUMSO
Status
Pending
Status Code
732
Status Date
Tuesday, August 27, 2024
Serial Number
90860790
Mark Type
4
Filing Date
Monday, August 2, 2021
Published for Opposition
Tuesday, January 17, 2023

Trademark Owner History
Bristol-Myers Squibb Company - Owner At Publication

Classifications
5 pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; pharmaceutical preparations for human use that modulate the immune system; pharmaceutical and biological preparations for human use for immunotherapy, namely t cell therapy; pharmaceutical preparations for human use, namely, stem cells for medical use; pharmaceutical preparations for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies

Trademark Events
Apr 26, 2022
Non-Final Action E-Mailed
Aug 5, 2021
New Application Entered
Sep 28, 2021
New Application Office Supplied Data Entered
Apr 19, 2022
Assigned To Examiner
Apr 26, 2022
Non-Final Action Written
Apr 26, 2022
Notification Of Non-Final Action E-Mailed
Oct 25, 2022
Teas Response To Office Action Received
Oct 25, 2022
Correspondence Received In Law Office
Oct 25, 2022
Teas/Email Correspondence Entered
Dec 8, 2022
Examiners Amendment -Written
Dec 8, 2022
Examiners Amendment E-Mailed
Dec 8, 2022
Notification Of Examiners Amendment E-Mailed
Dec 8, 2022
Examiner's Amendment Entered
Dec 12, 2022
Approved For Pub - Principal Register
Dec 28, 2022
Notification Of Notice Of Publication E-Mailed
Jan 17, 2023
Published For Opposition
Jan 17, 2023
Official Gazette Publication Confirmation E-Mailed
Mar 14, 2023
Noa E-Mailed - Sou Required From Applicant
Aug 2, 2023
Teas Change Of Owner Address Received
Aug 2, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Aug 2, 2023
Teas Change Of Correspondence Received
Aug 31, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 29, 2023
Sou Teas Extension Received
Aug 29, 2023
Sou Extension 1 Filed
Aug 29, 2023
Sou Extension 1 Granted
Aug 29, 2023
Sou Teas Extension Received
Sep 8, 2023
Case Assigned To Intent To Use Paralegal
Sep 8, 2023
Itu Letter Mailed, No Response Required
Feb 7, 2024
Sou Teas Extension Received
Aug 27, 2024
Sou Teas Extension Received
Aug 27, 2024
Notice Of Approval Of Extension Request E-Mailed
Aug 27, 2024
Sou Extension 3 Filed
Aug 27, 2024
Sou Extension 3 Granted
Feb 9, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 7, 2024
Sou Extension 2 Filed
Feb 7, 2024
Sou Extension 2 Granted

Trademark Alertz updated from USPTO on 2030-01-24